Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insmed Inc (NASDAQ:INSM)

30.33
Delayed Data
As of Nov 17
 -0.60 / -1.94%
Today’s Change
11.49
Today|||52-Week Range
32.94
+129.25%
Year-to-Date

Today’s Trading

Previous close30.93
Today’s open30.75
Day’s range29.92 - 30.95
Volume374,862
Average volume (3 months)1,210,492
Market cap$2.3B
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-41.09%
Earnings growth (this year)+5.76%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book12.18

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...-0.30-2.26%
ACRSAclaris Therapeutics...+0.21+0.93%
PRTKParatek Pharmaceutic...-0.05-0.24%
AKBAAkebia Therapeutics ...+0.23+1.52%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateFebruary 22, 2018
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$0.00
Annual profit (last year)-$176.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Will Lewis
Chief Financial Officer
Paolo Tombesi
Corporate headquarters
Bridgewater, New Jersey

Forecasts